Abstract:Abstract Background Ras-GTPase-activating protein binding protein 1 (G3BP1) is an oncogenic factor, which highly expressed in a variety of cancers. In recent years, G3BP1 has been reported to promote the development of prostate cancer by inhibiting the degradation of AR through inhibiting SPOP. However, whether G3BP1 contributes in a similar manner to the abnormal accumulation of ERα, which is also an important target for hormone therapy, remains unknown. This article addresses this issue and explores potential mechanisms. Methods Bioinformatics tools were used for G3BP1 expression analysis, survival analysis, and clinical association analysis. Immunohistochemical staining was used to examine the correlation between G3BP1 and ERα in EC patients. In addition, western blot and co-immunoprecipitation were used to detect the half-life of G3BP1 and mutant, and the effect of G3BP1 and mutant on the ubiquitination and degradation of ERα mediated by SPOP. Then, the oncogenic functions of G3BP1 dependent on the SPOP/ERα axis were determined by CCK8 cell proliferation assay, colony formation assay and cell migration assay. Finally, we established the EC cells treated or untreated with fulvestrant, exploring the possibility of fulvestrant combined with the reduction of G3BP1 to improve the efficacy of fulvestrant. Results G3BP1 is abnormally high expressed and characterized by high-frequency mutation in EC. In addition, there is a positive correlation between G3BP1 protein and ERα protein. Mechanistically, both G3BP1 and mutant, the latter is displaying the longer half-life, competitively bind SPOP with ERα, thereby inhibiting SPOP-mediated ubiquitination and degradation of ERα. Functionally, G3BP1 and mutant promote the proliferation and migration of EC cells by regulating the G3BP1/SPOP/ERα axis. However, fulvestrant can reverse the cancer-promoting effects of G3BP1 and mutant. Conclusions G3BP1 and its mutant positively regulate ERα signaling pathway by inhibiting SPOP-mediated ubiquitination and degradation of ERα, indicating the promising effect of fulvestrant on the suppression the occurrence and development of EC with high expressed G3BP1 and G3BP1 mutants.

Stress granule-associated protein G3BP2 regulates breast tumor initiation

G3BP1 promotes human breast cancer cell proliferation through coordinating with GSK-3β and stabilizing β-catenin

GASP1 enhances malignant phenotypes of breast cancer cells and decreases their response to paclitaxel by forming a vicious cycle with IGF1/IGF1R signaling pathway

G3BP1 Regulates Breast Cancer Cell Proliferation and Metastasis by Modulating PKCζ

G3BP2 promotes tumor progression and gemcitabine resistance in PDAC via regulating PDIA3-DKC1-hENT in a stress granules-dependent manner

Overexpression of Ras-GTPase-activating Protein SH3 Domain-Binding Protein 1 Correlates with Poor Prognosis in Gastric Cancer Patients.

G3BP1 Promotes Tumor Progression and Metastasis Through IL-6/G3BP1/STAT3 Signaling Axis in Renal Cell Carcinomas

Elevated Expression of G3BP1 Associates with YB1 and P‐akt and Predicts Poor Prognosis in Nonsmall Cell Lung Cancer Patients after Surgical Resection

G3BP2: Structure and function

Loss of Ras GTPase-activating protein SH3 domain-binding protein 1 (G3BP1) inhibits the progression of ovarian cancer in coordination with ubiquitin-specific protease 10 (USP10)

G3BP1 Interacts with YWHAZ to Regulate Chemoresistance and Predict Adjuvant Chemotherapy Benefit in Gastric Cancer

Translational Repression of G3BP in Cancer and Germ Cells Suppresses Stress Granules and Enhances Stress Tolerance

Regulation of PMP22 mRNA by G3BP1 affects cell proliferation in breast cancer cells

Gata Binding Protein 3 Boosts Extracellular Atp Hydrolysis And Inhibits Metastasis Of Breast Cancer By Up-Regulating Ectonucleoside Triphosphate Diphosphohydrolase 3

Loss of G3BP1 suppresses proliferation, migration, and invasion of esophageal cancer cells via Wnt/β‐catenin and PI3K/AKT signaling pathways

SHP2 Promotes Proliferation of Breast Cancer Cells Through Regulating Cyclin D1 Stability Via the PI3K/AKT/GSK3β Signaling Pathway

Endometrial cancer (EC) derived G3BP1 overexpression and mutant promote EC tumorigenesis and metastasis via SPOP/ERα axis

Protein phosphatase 1 regulatory inhibitor subunit 14C promotes triple‐negative breast cancer progression via sustaining inactive glycogen synthase kinase 3 beta

PGK1-coupled HSP90 Stabilizes GSK3β Expression to Regulate the Stemness of Breast Cancer Stem Cells

SHP2 promotes proliferation of breast cancer cells through regulating Cyclin D1 stability via the PI3K/AKT/GSK3β signaling pathway.

GOLPH3 Promotes Cancer Growth by Interacting with STIP1 and Regulating Telomerase Activity in Pancreatic Ductal Adenocarcinoma